Suppr超能文献

使用灵敏的纳米适配体传感器对癌症干细胞标志物进行荧光检测。

Fluorescence Detection of Cancer Stem Cell Markers Using a Sensitive Nano-Aptamer Sensor.

作者信息

Ding Jie, Xu Weiqiang, Tan Jing, Liu Zhifang, Huang Guoliang, Wang Shoushan, He Zhiwei

机构信息

Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, China.

Key Laboratory for Epigenetics of Dongguan City, China-America Cancer Research Institute, Guangdong Medical University, Dongguan, China.

出版信息

Front Chem. 2022 Jun 22;10:920123. doi: 10.3389/fchem.2022.920123. eCollection 2022.

Abstract

Antigen CD133 is a glycoprotein present on the surface of cancer stem cells (CSCs), which is a key molecule to regulate the fate of stem cells and a functional marker of stem cells. Herein, a novel fluorescence "turn-on" nano-aptamer sensor for quantifying CD133 was designed using hybridization between CD133-targeted aptamers and partially complementary paired RNA (ssRNA), which were modified on the surface of quantum dots (QDs) and gold nanoparticles (AuNPs), respectively. Owing to the hybridization of aptamers and ssRNA, the distance between QDs and AuNPs was shortened, which caused fluorescence resonance energy transfer (FRET) between them, and the florescence of QDs was quenched by AuNPs. When CD133 competitively replaced ssRNA and was bound to aptamers, AuNPs-ssRNA could be released, which led to a recovery of fluorescent signals of QDs. The increase in the relative value of fluorescence intensity was investigated to linearly correlate with the CD133 concentration in the range of 0-1.539 μM, and the detection limit was 6.99 nM. In confocal images of A549 cells, the CD133 aptamer sensor was further proved applicable in lung cancer cell samples with specificity, precision, and accuracy. Compared with complicated methods, this study provided a fresh approach to develop a highly sensitive and selective detection sensor for CSC markers.

摘要

抗原CD133是一种存在于癌症干细胞(CSCs)表面的糖蛋白,它是调节干细胞命运的关键分子和干细胞的功能标志物。在此,利用靶向CD133的适体与部分互补配对的RNA(ssRNA)之间的杂交设计了一种用于定量CD133的新型荧光“开启”纳米适体传感器,它们分别修饰在量子点(QDs)和金纳米颗粒(AuNPs)的表面。由于适体与ssRNA的杂交,QDs与AuNPs之间的距离缩短,导致它们之间发生荧光共振能量转移(FRET),并且QDs的荧光被AuNPs淬灭。当CD133竞争性取代ssRNA并与适体结合时,AuNPs-ssRNA可以被释放,这导致QDs荧光信号的恢复。研究了荧光强度相对值的增加与0-1.539μM范围内CD133浓度的线性关系,检测限为6.99 nM。在A549细胞的共聚焦图像中,进一步证明了CD133适体传感器适用于肺癌细胞样本,具有特异性、精确性和准确性。与复杂的方法相比,本研究为开发用于癌症干细胞标志物的高灵敏度和选择性检测传感器提供了一种新方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be16/9257163/e2532979f549/fchem-10-920123-g010.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验